Broad canine oral parasiticide gets FDA approvalOctober 8, 2024The single monthly dose parasiticide is recommended to protect against six parasites, including fleas, ticks, heartworms, hookworms, and tapeworms.
SPONSORED CONTENTStart Treating Canine MMVD Patients at Stage B2Learn about early treatment with pimobendan for canine Stage B2 preclinical MMVD patients. + Learn More
Puppy parasiticide chews get green lightJuly 13, 2020Ensuring puppies receive early protection from fleas and ticks is the goal of a newly approved chewable parasiticide.
Pharma group rounds out parasite protections in $400M dealMay 14, 2020Merck Animal Health’s acquisition of Virbac’s proprietary products expands the company’s offerings of internal parasite preventatives.
